Showing results (341-350 of 355) with videos related to

Sort By:
Pageof 36
Science (New York, N.Y.)|January 6, 1978
Viking first encounter of phobos: preliminary resultsR H Tolson, T C Duxbury, G H Born, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2003
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trialAdriano Paccagnella, A Favaretto, F Oniga, et al.
The New England Journal of Medicine|September 22, 1977
Inefficacy of immediate node dissection in stage 1 melanoma of the limbsU Veronesi, J Adamus, D C Bandiera, et al.
Tumori|June 30, 1980
Stage I melanoma of the limbs. Immediate versus delayed node dissectionU Veronesi, J Adamus, D C Bandiera, et al.
Cancer|June 1, 1982
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremitiesU Veronesi, J Adamus, D C Bandiera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemC M Balch, S J Soong, J E Gershenwald, et al.
The New England Journal of Medicine|October 7, 1982
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanomaU Veronesi, J Adamus, C Aubert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2026
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARDJ W Riess, H A Yu, X Le, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialF Perrone, F Nuzzo, F Di Rella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE studyF Nuzzo, C Gallo, S Lastoria, et al.
Pageof 36